Skip to main content

Bartter, Liddle, and Conn Syndromes


Bartter, Liddle, and Conn Syndromes

A practical comparison of salt-handling disorders causing metabolic alkalosis

Disorders of renal sodium handling are frequently tested and clinically relevant because they present with characteristic patterns of blood pressure, electrolytes, and hormonal changes. Bartter syndrome, Liddle syndrome, and Conn syndrome all cause metabolic alkalosis but differ fundamentally in their mechanisms and clinical profiles.

---

Bartter Syndrome

Salt-wasting disorder mimicking chronic loop diuretic use


Bartter syndrome is a hereditary defect of ion transport in the thick ascending limb of the loop of Henle, most commonly involving the Na–K–2Cl cotransporter (NKCC2) or related channels.


Pathophysiology


Impaired sodium reabsorption in the loop of Henle


Renal sodium loss → extracellular volume depletion


Secondary activation of RAAS


Increased distal sodium delivery → potassium and hydrogen ion loss



Key Biochemical Changes


Increased


Renin


Aldosterone



Decreased


Sodium


Blood volume


Potassium



Clinical Features


Normal or low blood pressure (no hypertension despite high aldosterone)


Polyuria, polydipsia


Growth retardation (pediatric cases)


Metabolic alkalosis



Core Concept


> High renin, high aldosterone, no hypertension





---


Liddle Syndrome


Pseudohyperaldosteronism


Liddle syndrome is a rare genetic disorder caused by constitutive activation of the epithelial sodium channel (ENaC) in the collecting duct.


Pathophysiology


Excessive sodium reabsorption independent of aldosterone


Volume expansion → suppression of RAAS


Increased potassium and hydrogen ion secretion



Key Biochemical Changes


Increased


Sodium


Blood volume


Blood pressure



Decreased


Renin


Aldosterone


Potassium



Clinical Features


Early-onset hypertension


Hypokalemia


Metabolic alkalosis


Poor response to spironolactone



Treatment Principle


ENaC blockers: amiloride or triamterene



Core Concept


> Hypertension without aldosterone





---


Conn Syndrome (Primary Hyperaldosteronism)


True aldosterone excess


Conn syndrome is caused by autonomous aldosterone secretion, usually from an adrenal adenoma or bilateral adrenal hyperplasia.


Pathophysiology


Excess aldosterone → increased sodium reabsorption


Volume expansion → suppressed renin


Increased potassium and hydrogen ion excretion



Key Biochemical Changes


Increased


Sodium


Blood volume


Blood pressure


Aldosterone



Decreased


Renin


Potassium



Clinical Features


Resistant hypertension


Hypokalemia (may be mild or absent)


Metabolic alkalosis



Diagnostic Clue


High aldosterone-to-renin ratio



Core Concept


> Hypertension due to high aldosterone





---


Side-by-Side Summary


Feature Bartter Liddle Conn


Primary defect NKCC2 / loop transport ENaC overactivity Aldosterone excess

Blood pressure Normal / low High High

Renin ↑ ↓ ↓

Aldosterone ↑ ↓ ↑

Potassium ↓ ↓ ↓

Acid–base status Metabolic alkalosis Metabolic alkalosis Metabolic alkalosis

Key clue Salt wasting, no HTN HTN without aldosterone HTN with high aldosterone




---


Exam Pearls


Bartter = diuretics effect + no hypertension


Liddle = low renin, low aldosterone, hypertension


Conn = low renin, high aldosterone, hypertension




---


For more cardiology and medicine infographics, visit:

drmusmanjaved.com



Comments

Popular posts from this blog

Brugada ECG vs Incomplete Right Bundle Branch Block (iRBBB)

Brugada ECG vs Incomplete Right Bundle Branch Block (iRBBB) Why this differentiation matters Brugada pattern is a malignant channelopathy associated with sudden cardiac death, while incomplete RBBB is usually a benign conduction variant. Mislabeling Brugada as iRBBB can be fatal; overcalling iRBBB as Brugada can lead to unnecessary anxiety and ICD implantation. --- 1. Basic Definitions Brugada ECG Pattern Primary repolarization abnormality Genetic sodium-channel disorder Characteristic ST-segment elevation in V1–V3 Risk of ventricular fibrillation and sudden death Incomplete RBBB (iRBBB) Depolarization abnormality Delay in right ventricular conduction Common in healthy individuals Usually asymptomatic and benign --- 2. ECG Morphology: Side-by-Side Comparison QRS Duration Brugada: QRS usually <120 ms iRBBB: QRS <120 ms, but with RBBB morphology --- V1–V2 Pattern (Key Differentiator) Brugada Pseudo-RBBB appearance ST elevation ≥2 mm ST segment is coved or saddleback Terminal QRS bl...

π˜Όπ™£π™©π™žπ™˜π™€π™–π™œπ™ͺπ™‘π™–π™©π™žπ™€π™£ π˜Όπ™›π™©π™šπ™§ π™Žπ™©π™§π™€π™ π™š

 π˜Όπ™£π™©π™žπ™˜π™€π™–π™œπ™ͺπ™‘π™–π™©π™žπ™€π™£ π˜Όπ™›π™©π™šπ™§ π™Žπ™©π™§π™€π™ π™š in  Patient with AF and acute IS/TIA European Heart Association Guideline recommends: • 1 days after TIA • 3 days after mild stroke • 6 days after moderate stroke • 12 days after severe stroke Early anticoagulation can decrease a risk of recurrent stroke and embolic events but may increase a risk of secondary hemorrhagic transformation of brain infarcts.  The 1-3-6-12-day rule is a known consensus with graded increase in delay of anticoagulation between 1 and 12 days after onset of ischemic stroke or transient ischemic attack(TIA), according to neurological severity based on European expert opinions. However, this rule might be somewhat later than currently used in a real-world practical setting.

Acute Treatment of Hyperkalemia

Acute Treatment of Hyperkalemia – A Practical, Bedside-Oriented Guide Hyperkalemia is a potentially life-threatening electrolyte abnormality that demands prompt recognition and decisive management. The danger lies not only in the absolute potassium value but in its effects on cardiac conduction, which can rapidly progress to fatal arrhythmias. Acute treatment focuses on three parallel goals: stabilizing the cardiac membrane, shifting potassium into cells, and removing excess potassium from the body. Understanding this stepwise approach helps clinicians act quickly and rationally in emergency settings. Why Hyperkalemia Is Dangerous Potassium plays a key role in maintaining the resting membrane potential of cardiac myocytes. Elevated serum potassium reduces the transmembrane gradient, leading to slowed conduction, ECG changes, ventricular arrhythmias, and asystole. Importantly, ECG changes do not always correlate with potassium levels, so treatment decisions should be based on clinical c...